TH
Themis Medicare Ltd (THEMISMED)
₹113.40
Mkt cap
₹1,142 Cr
P/E ratio
—
P/B
2.62
Div yield
0.40%
ROE
0.41%
ROCE
2.74%
EPS (TTM)
—
Book value
₹43
52W range
65–147
Sector
Healthcare
Price history
Previous close
Incorporated in 1969, Themis Medicare manufactures Formulation and API pharmaceutical products [1]
NSE THEMISMEDBSE 530199
Health check
Cautious
ProfitabilityWeak
GrowthLow
TechnicalsNeutral
52-week range
−22.86% from high₹113
₹65+74.60% from low₹147
Current
₹113.40
Prev close
₹114.56
Day
−1.01%
Price performance
1D
−1.01%
1W
−2.95%
1M
−9.19%
3M
−2.89%
6M
+43.15%
1Y
−13.98%
YTD
+10.60%
Financials
Revenue, profit & margin
| Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | Trend | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 97 | 105 | 83 | 98 | 123 | 117 | 94 | 72 | 98 | 78 | 90 | 77 | 87 | |
| Expenses | 75 | 92 | 74 | 89 | 94 | 100 | 88 | 79 | 108 | 81 | 80 | 73 | 139 | |
| Operating Profit | 22 | 12 | 8 | 9 | 29 | 17 | 6 | -8 | -10 | -3 | 10 | 4 | -52 | |
| OPM % | 22% | 12% | 10% | 10% | 24% | 15% | 6% | -11% | -10% | -4.0% | 11% | 4.9% | -60% | |
| Other Income | 6 | 7 | 6 | 5 | 7 | 6 | 1 | 2 | 1 | 5 | 6 | 11 | 97 | |
| Interest | 2 | 2 | 3 | 2 | 2 | 2 | 3 | 2 | 2 | 3 | 3 | 3 | 3 | |
| Depreciation | 3 | 3 | 3 | 3 | 2 | 2 | 3 | 3 | 3 | 3 | 3 | 3 | 3 | |
| Profit before tax | 23 | 14 | 8 | 9 | 31 | 18 | 2 | -11 | -14 | -3 | 10 | 9 | 39 | |
| Tax % | 19% | 19% | 10% | 24% | 21% | 20% | 69% | -13% | 1% | 5% | 3% | 2% | 36% | |
| Net Profit | 18 | 11 | 7 | 7 | 25 | 14 | 1 | -10 | -14 | -4 | 10 | 9 | 25 | |
| EPS in Rs | 1.98 | 1.23 | 0.80 | 0.72 | 2.68 | 1.55 | 0.06 | -1.05 | -1.54 | -0.39 | 1.10 | 0.97 | 2.67 | |
| Raw PDF |
Earnings
Results dates & reactionsNo upcoming results date on calendar.
Fresh quarters land in the Financials table above, tagged NSE until screener catches up.
Avg earnings-day move −4.31% · closed higher next day 0 of last 1
| Q1FY27 | |
|---|---|
| Broadcast | 13 Aug '26 |
| Earnings day | −4.31% |
| +1 day | −3.49% |
| +5 days | −5.40% |
| +15 days | +14.94% |
| +30 days | +7.63% |
| Filing | XBRL |
Corporate actions
Last 6 monthsNo recent corporate actions
Dividends, splits, and bonuses in the last six months show up here.
Shareholding
as of Jun 202667.10%Promoter
Promoters67.10%
FIIs0.01%0.10
DIIs0.01%
Public32.87%0.09
Ownership trend
Peers
8 companiesValuation vs quality
P/E × ROCE · bubble = market cap| Name | CMP | P/E | Mkt Cap | Div Yld | NP Qtr | Qtr Profit Var | Sales Qtr | Qtr Sales Var | ROCE |
|---|---|---|---|---|---|---|---|---|---|
| Sun Pharma.Inds. | ₹1,837.30 | 34.90 | 4,40,830 | 0.87% | 2,901 | +5.95% | 15,300 | +10.46% | 20.53% |
| Divi's Lab. | ₹9,375.00 | 83.54 | 2,48,877 | 0.32% | 902 | +65.50% | 3,080 | +27.80% | 21.97% |
| Torrent Pharma. | ₹4,840.00 | 82.51 | 1,84,098 | 0.79% | 566 | +5.79% | 4,921 | +54.85% | 15.19% |
| Zydus Lifesci. | ₹1,160.00 | 23.77 | 1,15,710 | 0.09% | 990 | −35.09% | 8,017 | +21.96% | 21.14% |
| Cipla | ₹1,394.50 | 31.48 | 1,12,656 | 0.93% | 786 | −39.19% | 7,119 | +2.33% | 15.49% |
| Laurus Labs | ₹1,954.00 | 96.56 | 1,05,577 | 0.10% | 362 | +125.49% | 2,026 | +29.10% | 17.76% |
| Aurobindo Pharma | ₹1,734.00 | 26.39 | 99,771 | 0.23% | 1,032 | +28.11% | 9,150 | +16.30% | 12.86% |
| Themis Medicare | ₹123.97 | — | 1,142 | 0.40% | 25 | −282.28% | 87 | −10.88% | 2.74% |
| Median: 158 Co. | ₹433.90 | 34.56 | 2,205 | 0.08% | 13 | +29.57% | 164 | +18.57% | 14.96% |
Filings
Annual reports15
Concall transcripts22
Credit ratings6
Announcements5
Corporate Action -Fixed Record Date For Dividend For FY 2025-26. 18 Sep - Record date set for final dividend FY2025-26 on September 23, 2026; AGM on September 30, 2026.Announcement under Regulation 30 (LODR)-Newspaper Publication 9 Sep - Please refer to Newspaper publication for Notice of 56th AGM scheduled on 30th September, 2026.Notice Of 56Th Annual General Meeting Scheduled On 30.09.2026 8 SepReg. 34 (1) Annual Report. 8 SepBusiness Responsibility and Sustainability Reporting (BRSR) 8 Sep - 56th AGM on 30 September 2026; annual report, dividend proposal, director reappointment and AoA amendment.